Skip to content
INVESTOR | Expres2ion Biotech

INVESTOR | Expres2ion Biotech

Investor Relations

  • News & Events
    • Press Releases
    • Upcoming Events
    • Presentations
    • Financial Calendar
  • Financials
    • Financial reports
  • Governance
    • Articles of Association
    • Management Team
    • Board of Directors
    • General Meetings
    • Company Description
  • Stock Information
    • Stock Quote & Largest Shareholders
    • Analyst Reports
    • IPO and Rights Issues
      • Rights issue 2026
      • Rights Issue 2024
      • Rights Issue 2023
      • Rights Issue 2022
      • Rights Issue 2020
      • Rights Issue 2018
      • Rights Issue 2017
      • Rights Issue 2016 (IPO)
  • Corporate Site

  • Home
  • Pages
Loading Events

« All Events

  • This event has passed.

Interim report, Q3 2022

17/11/22
  • « Half-year report, 2022
  • Year-end report, 2022 »
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live

Details

  • Date: 17/11/22
  • Event Category: Financial Calendar
  • « Half-year report, 2022
  • Year-end report, 2022 »

Copyright 2010 - All Rights Reserved

EXPRES2ION BIOTECH HOLDING AB
Registration number: 559033-3729
c/o Mindpark
Rönnowsgatan 8C
SE-252 25 Helsingborg, Sweden

R&D
ExpreS2ion Biotechnologies ApS:
CVR/VAT: DK32770487
Agern Allé 1
DK-2970 Hørsholm, Denmark

INVESTOR RELATIONS
investor@expres2ionbio.com

Contact investor relations

MORE INFO
Privacy Policy
Terms & General Conditions
Legal Notice & Disclaimer

Copyright © 2026 INVESTOR | Expres2ion Biotech All rights reserved. Theme: Flash by ThemeGrill. Powered by WordPress